Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05190900
Other study ID # 3010201915819 B
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 29, 2022
Est. completion date September 7, 2022

Study information

Verified date August 2022
Source Mayuben Private Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigation will consist of measuring before and after applying nerve mobilization exercise. Measurements will be made on the same day without the need to go at another time. In this study, participants will be asked to stand on a pressure platform several times in a relaxed manner and with eyes open and closed before and after a neuromeningeal mobilization technique indicated for the treatment of pain in your feet. Measurements or tests to be carried out are totally innocuous and do not carry any risk to your health and integrity. Participants will have to remain barefoot for a maximum of 30 seconds, a total of 8 times on a pressure platform


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date September 7, 2022
Est. primary completion date September 5, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Participants were diagnosed with active or latent MTrP in bilateral flexor digitorum brevis. - MTrPs were the only MTrPs diagnosed in limb or foot. - Participants had a normal body mass. - Age range of 20 to 40 years. Exclusion criteria: - Diagnosis of lower limb injury. - History of previous lower extremity surgery. - Required not to have undergone ankle stretching or any other treatment - Diabetes due to possible elevation of plantar pressure. - Deformities of the toes, such as hammer toes and hallux valgus due to their possible alteration in plantar pressure.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
neural mobilization
neural mobilisation of the posterior tibial, deep peroneal and lateral, intermediate and medial dorsocutaneous nerves.

Locations

Country Name City State
Spain EVA MARIA Martínez Madrid

Sponsors (1)

Lead Sponsor Collaborator
Mayuben Private Clinic

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stabilometry variable x displacement open eyes before Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with open eyes. Through study completion, an average of 2 days
Primary Stabilometry variable y displacement open eyes before Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with open eyes. Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure area open eyes before Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes open. Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction open eyes Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second). Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction open eyes before Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second). Through study completion, an average of 2 days
Primary Stabilometry variable x displacement before Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with eyes closed. Through study completion, an average of 2 days
Primary Stabilometry variable y displacement before Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with closed eyes. Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure area before Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes closed. Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction before Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second). Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction before Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second). Through study completion, an average of 2 days
Primary Stabilometry variable x displacement open eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with open eyes. Through study completion, an average of 2 days
Primary Stabilometry variable y displacement open eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with open eyes. Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure area open eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes open. Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction with open eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second). Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction with open eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second). Through study completion, an average of 2 days
Primary Stabilometry variable x displacement with closed eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with eyes closed. Through study completion, an average of 2 days
Primary Stabilometry variable y displacement with closed eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with closed eyes. Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure area with closed eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes closed. Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction with closed eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second). Through study completion, an average of 2 days
Primary Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction with closed eyes after intervention Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second). Through study completion, an average of 2 days
See also
  Status Clinical Trial Phase
Recruiting NCT04458480 - Effect of Fast Inpatient Rehabilitation After TKA
Recruiting NCT06238596 - Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study) N/A
Recruiting NCT05547152 - Evaluation of the Effectiveness of Virtual Reality Self-rehabilitation in the Treatment of Facial Paralysis and Synkinesis N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Completed NCT03661944 - Functional Performance Assessments in Overhead Athletes With Shoulder Injury
Completed NCT05875480 - The Effectiveness of Telerehabilitation After Arthroscopic Meniscus Repair N/A
Not yet recruiting NCT05854056 - Tibial Tubercle Distalisation and Accelerated Rehabilitation N/A
Not yet recruiting NCT05177380 - Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis N/A
Not yet recruiting NCT04419753 - The Role of Attention Focus Walking Training in Older Adults. N/A
Not yet recruiting NCT03628495 - Effectiveness of a Combined Pressure and Silicone Intervention for Hypertrophic Scar Treatment N/A
Completed NCT02413996 - Effects of Virtual Reality Rehabilitation in Patients With Total Knee Arthroplasty N/A
Completed NCT01205542 - Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck (VIMS) - Shoulder Function N/A
Completed NCT02644096 - Rehabilitation of Patients After THR - Based on Patients´Selfrated Health Phase 1
Completed NCT03582371 - Aqua Stand-Up Paddle Balance Effect in Parkinson's Disease (AquaSUP PARK) N/A
Completed NCT05655039 - The Effect of Pre-rehabilitation and Rehabilitation Period on Functional Status in Inpatient Stroke Patients
Completed NCT04502654 - Rehabilitation for Thoracoscopic Lobectomy
Completed NCT06206018 - Patient-Reported Outcome Measures in Lower Extremity Rehabilitation Program PROM_R: Impact on Health Care N/A
Completed NCT03386604 - Physical Capacity of Patients With Chronic Obstructive Pulmonary Disease With and Without Supplementation of Whey N/A
Recruiting NCT05619666 - Acute Rehabilitation in Patients With COVID-19 Pneumonia N/A
Completed NCT06251791 - Inspiratory Muscle Training and Expiratory Muscle Thickness N/A